Premium
When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH
Author(s) -
Levy J. H.,
Ageno W.,
Chan N. C.,
Crowther M.,
Verhamme P.,
Weitz J. I.
Publication year - 2016
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/jth.13227
Subject(s) - apixaban , edoxaban , rivaroxaban , dabigatran , medicine , atrial fibrillation , vitamin k , stroke (engine) , intracranial bleeding , intensive care medicine , warfarin , mechanical engineering , engineering
J . H . LEVY ,* W. AGENO,† N. C . CHAN,‡ M. CROWTHER ,§ P . VERHAMME ¶ and J . I . WE ITZ ,§ FOR THE SUBCOMMITTEE ON CONTROL OF ANT ICOAGULAT ION *Duke University School of Medicine, Durham, NC, USA; †University of Insubria, Varese, Italy; ‡Monash University, Clayton, Vic., Australia; §McMaster University and the Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada; and ¶University of Leuven, Leuven, Belgium